THANC Foundation logo 1

Our site uses cookies and we've updated our privacy policy.

Got it
Diagnostics October 30th, 2018

Tumor Epidermal Growth Factor Receptor and EGFR PY1068 are Independent Prognostic Indicators for Head & Neck Squamous Cell Carcinoma

Epidermal growth factor receptor (EGFR) has been recognized as contributing to head and neck squamous cell carcinoma (HNSCC) development and progression, but the prognostic value of many specific EGFR molecular characteristics have not been evaluated alone or in combination. This study was carried out by THANC to define the relationship between EGFR gene amplification, gene expression, and protein and phosphoprotein levels in prospectively collected tumor tissues from a cohort of HNSCC patients treated with surgery with curative intent.

Apply for the Research Associate Program

Required Documents

Each file should be no more than 2mb in size. Only PDFs accepted.